Skip to content
  • Tuesday, 29 September 2026
  • 5:27 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • New Stanford Medicine Study Reveals Protein-Targeting Treatment Restores Lost Knee Cartilage and Prevents Osteoarthritis in Preclinical Trials
Stem Cell & Regenerative Medicine

New Stanford Medicine Study Reveals Protein-Targeting Treatment Restores Lost Knee Cartilage and Prevents Osteoarthritis in Preclinical Trials

Dwi Wanna Sep 26, 2026 0

A groundbreaking scientific discovery led by researchers at Stanford Medicine has demonstrated that targeting a specific protein linked to the…

Read More
Stem Cell & Regenerative Medicine

Groundbreaking Human Skeletal Blueprint Unveiled: Shedding Light on Congenital Bone Disorders, Osteoarthritis, and Pregnancy Drug Safety

Dwi Wanna Sep 16, 2026 0

Researchers at the Wellcome Sanger Institute, working alongside an international consortium of collaborators, have published the first comprehensive cellular blueprint…

Read More
Stem Cell & Regenerative Medicine

Stanford Researchers Discover Protein Inhibitor That Reverses Cartilage Loss and Prevents Osteoarthritis

Dwi Wanna Jul 20, 2026 0

In a breakthrough that could fundamentally alter the treatment landscape for degenerative joint diseases, researchers at Stanford Medicine have identified…

Read More
Stem Cell & Regenerative Medicine

Stanford Researchers Identify Gerozyme Inhibitor That Regenerates Cartilage and Reverses Osteoarthritis Symptoms

Dwi Wanna Jul 13, 2026 0

In a landmark study that could redefine the treatment of degenerative joint diseases, researchers at Stanford Medicine have demonstrated that…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Study Reveals Potential Breakthrough in Reversing Osteoarthritis Through Gerozyme Inhibition and Cartilage Regeneration

Dwi Wanna Jul 5, 2026 0

The landscape of regenerative medicine has shifted following a landmark study led by Stanford Medicine researchers, which demonstrates that targeting…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Researchers Identify Protein Inhibitor That Regenerates Lost Knee Cartilage and Reverses Osteoarthritis Damage

Dwi Wanna Jun 28, 2026 0

In a landmark study that could redefine the treatment of degenerative joint diseases, a research team led by Stanford Medicine…

Read More
Stem Cell & Regenerative Medicine

Stanford University Study Reveals Gerozyme Inhibitor Capable of Regenerating Damaged Knee Cartilage and Halting Osteoarthritis Progression

Dwi Wanna Jun 20, 2026 0

A groundbreaking study led by researchers at Stanford Medicine has identified a therapeutic pathway that restores lost knee cartilage in…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Study Identifies Gerozyme Inhibitor Capable of Regenerating Knee Cartilage and Reversing Osteoarthritis Damage

Dwi Wanna Jun 13, 2026 0

A landmark study led by researchers at Stanford Medicine has identified a potential pharmacological breakthrough that could fundamentally alter the…

Read More
NYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AILife Beyond Earth May Be Revealed by Hidden Chemical PatternsBrain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune LandscapeScience News: A Century of Independent Journalism and the Evolution of Scientific Literacy
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
DNA Reveals Four Gentoo Penguin Species and Rewrites Antarctic Evolutionary HistoryTolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m DealUnprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before DiagnosisAs the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
YOU MAY HAVE MISSED
Molecular & Cell Biology
DNA Reveals Four Gentoo Penguin Species and Rewrites Antarctic Evolutionary History
Angie Faith Sep 29, 2026
Pharmaceutical R&D
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m Deal
Teuku Ryan Sep 29, 2026
Stem Cell & Regenerative Medicine
Unprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before Diagnosis
Dwi Wanna Sep 29, 2026
Laboratory Automation & Robotics
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
Lana Keisha Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ